Paola Di Nardo

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

Jesse J. Swen, Cathelijne H. van der Wouden, Lisanne E. N. Manson et al. · The Lancet · 2023 · 514 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Prognostic role of visceral fat for overall survival in metastatic colorectal cancer: A pilot study

Debora Basile, Michele Bartoletti, Maurizio Polano et al. · Clinical Nutrition · 2020 · 35 citations

Medicine, Oncology, Gastrointestinal Oncology +16

Liquid biopsy in colorectal cancer: Onward and upward

Sara Torresan, Marco de Scordilli, Martina Bortolot et al. · Critical Reviews in Oncology/Hematology · 2023 · 19 citations

Medicine, Oncology, Pathology +11

The SENECA study: Prognostic role of serum biomarkers in older patients with metastatic colorectal cancer

C. Lisanti, Debora Basile, A. Parnofiello et al. · Journal of Geriatric Oncology · 2020 · 14 citations

Medicine, Geriatric Medicine, Oncology +16

The SAFFO Study: Sex-Related Prognostic Role and Cut-Off Definition of Monocyte-to-Lymphocyte Ratio (MLR) in Metastatic Colorectal Cancer

C. Lisanti, Debora Basile, Silvio Ken Garattini et al. · Cancers · 2022 · 12 citations · Full text

Medicine, Immunology, Oncology +16